CliffBio

Indivior

Patent cliffs & loss of exclusivity

A specialty pharmaceuticals business

Company

Legal NameIndivior PLC
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/indivior
Legal Entity Identifier213800V3NCQTY7IED471
LinkedIn URLhttps://www.linkedin.com/company/indivior/
Pitchbook URLhttps://pitchbook.com/profiles/company/65416-96
Stock SymbolINVVY
Official Websitehttp://indivior.com

9 upcoming patent cliffs

DrugIngredientTypeCliff
  1. PERSERIS KITRISPERIDONESmall mol.Feb 2028
  2. PERSERIS KITRISPERIDONESmall mol.Feb 2028
  3. SUBOXONEBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDESmall mol.Mar 2030
  4. SUBOXONEBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDESmall mol.Mar 2030
  5. SUBOXONEBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDESmall mol.Mar 2030
  6. SUBOXONEBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDESmall mol.Mar 2030
  7. SUBLOCADEBUPRENORPHINESmall mol.Nov 2035
  8. SUBLOCADEBUPRENORPHINESmall mol.Jun 2038
  9. OPVEENALMEFENE HYDROCHLORIDESmall mol.Aug 2042
  10. BUPRENEXBUPRENORPHINE HYDROCHLORIDESmall mol.—
  11. SUBOXONEBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDESmall mol.—
  12. SUBOXONEBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDESmall mol.—
  13. SUBUTEXBUPRENORPHINE HYDROCHLORIDESmall mol.—
  14. SUBUTEXBUPRENORPHINE HYDROCHLORIDESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.